Actively Recruiting
Study of LYMPHA Procedure to Prevent Lymphedema in Women Undergoing Axillary Lymphadenectomy for Breast Cancer
Led by Stanford University · Updated on 2026-08-12
100
Participants Needed
1
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Lymphedema is a long-lasting and worsening condition caused by problems with the lymphatic system, often happening after breast cancer treatment. This trial aims to see if a low-risk lymphatic reconstruction technique done during axillary lymph node removal can lower the chance of developing lymphedema. It also examines if this surgery improves measurable lymphedema outcomes and patient quality of life. Participants will be randomly assigned to one of three groups one receiving axillary lymphadenectomy alone, another having axillary lymphadenectomy with soft tissue reinforcement, and the last group undergoing axillary lymphadenectomy with immediate lymphatic reconstruction LYMPHA using reverse mapping and the SPY System. These procedures are compared to assess their effects on lymphedema prevention. During the study, participants will be monitored for up to two years to measure lymphatic flow patterns, limb volume, skin thickness, bioimpedance spectroscopy, and quality of life specific to limb lymphedema using the LYMQOL tool. These assessments help track the impact of the procedures on lymphedema development and patient well-being over time.
CONDITIONS
Brief Title
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
Research Team
D
Dung Nguyen, MD, PharmD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here